• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4618911)   Today's Articles (966)   Subscriber (49402)
For: Al-Mansouri L, Arasaratnam M, Gurney H. Continuing cabazitaxel beyond 10 cycles for metastatic castrate-resistant prostate cancer: is there a benefit? Eur J Hosp Pharm 2021;28:83-87. [PMID: 33608435 DOI: 10.1136/ejhpharm-2019-001955] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2019] [Revised: 04/29/2019] [Accepted: 05/08/2019] [Indexed: 11/04/2022]  Open
Number Cited by Other Article(s)
1
Joshua AM, Gurney H, Dhillon HM, Crumbaker M. Patient Preference or Indifference: Learning from the CABADOC Study. Eur Urol 2021;81:241-242. [PMID: 34836681 DOI: 10.1016/j.eururo.2021.11.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2021] [Accepted: 11/05/2021] [Indexed: 11/04/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA